| 摘要 |
The invention relates to compounds of formula A: (A) or a salt, solvate, hydrate, or prodrug thereof. The compounds of Formula A are TGR5 modulators. In some embodiments, the compounds of Formula A are TGR5 receptor agonists and are useful in the treatment of obesity and/or diabetes in a subject. |
